Effect of non-nucleoside reverse transcriptase inhibitors and protease inhibitors on serum levels of myeloperoxidase and C-reactive protein in HIV-infected individuals. Braz. J. Pharm. Sci. 2022;58. doi:10.1590/s2175-97902020000118780